Philadelphia Pharmaceuticals Company (ASE:PHIL)
Jordan · Delayed Price · Currency is JOD 1.590
0.00 (0.00%)
At close: May 10, 2026
ASE:PHIL Revenue
Philadelphia Pharmaceuticals Company had revenue of 2.17M JOD in the quarter ending March 31, 2026, a decrease of -7.02%. This brings the company's revenue in the last twelve months to 9.00M, up 1.92% year-over-year. In the year 2025, Philadelphia Pharmaceuticals Company had annual revenue of 9.17M with 4.64% growth.
Revenue (ttm)
9.00M
Revenue Growth
+1.92%
P/S Ratio
1.34
Revenue / Employee
69.81K
Employees
129
Market Cap
12.08M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 9.17M | 406.53K | 4.64% |
| Dec 31, 2024 | 8.76M | 357.51K | 4.25% |
| Dec 31, 2023 | 8.40M | -10.46K | -0.12% |
| Dec 31, 2022 | 8.42M | 1.81M | 27.48% |
| Dec 31, 2021 | 6.60M | -1.05M | -13.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition